Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin gets USFDA EIR for Pithampur Unit 3 facility

Ruchika Sharma6 Nov 2025 11:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and...

Venus Remedies expands presence in Vietnam with marketing nods for Methotrexate, Cefuroxime, Irinotecan

Ruchika Sharma6 Nov 2025 10:15 AM IST

Venus Remedies Limited has received new marketing authorizations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam. These regulatory approvals...

Alembic Pharma net profit up 21 percent at Rs 185 crore in Q2

Ruchika Sharma5 Nov 2025 4:13 PM IST

New Delhi: Alembic Pharmaceuticals Ltd has reported a 21 percent year-on-year rise in consolidated net profit to Rs 185 crore for the quarter ended...

USFDA approves Marksans Pharma anti-diarrheal medication

USFDA issues 9 observations for Canada contract manufacturing facility: Jubilant Pharmova

Ruchika Sharma5 Nov 2025 2:45 PM IST

Noida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded an audit of Jubilant...

Zydus Wellness net sales up by 31 percent in Q2 FY26

Ruchika Sharma5 Nov 2025 2:15 PM IST

Ahmedabad: Reporting its second quarter results for FY 26, Zydus Wellness Limited, has reported a growth of 31 percent in Net Sales which...

Granules Life Sciences gets USFDA approval for Hyderabad Facility

USFDA inspection: Granules India Virginia arm gets EIR

Ruchika Sharma5 Nov 2025 1:45 PM IST

Hyderabad: Granules India has announced that the United States Food and Drug Administration (US FDA) has issued an Establishment Inspection...

Zydus Amplitude receives CE mark for robotic surgical system Andy

Zydus gets EIR for SEZ II manufacturing facility in Ahmedabad

Ruchika Sharma5 Nov 2025 12:45 PM IST

Ahmedabad: Zydus has announced that the company has received an Establishment Inspection Report (EIR) from the United States Food and Drugs...

$Roche Lunsumio subcutaneous secures European Commission approval for refractory follicular lymphoma$

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok

Articles By : Ruchika Sharma

Lupin gets USFDA EIR for Pithampur Unit 3 facility

Venus Remedies expands presence in Vietnam with marketing nods for Methotrexate, Cefuroxime, Irinotecan

Alembic Pharma net profit up 21 percent at Rs 185 crore in Q2

USFDA issues 9 observations for Canada contract manufacturing facility: Jubilant Pharmova

Zydus Wellness net sales up by 31 percent in Q2 FY26

USFDA inspection: Granules India Virginia arm gets EIR

Zydus gets EIR for SEZ II manufacturing facility in Ahmedabad

Marksans Pharma UK arm gets marketing nod for Exemestane 25mg film-coated tablets

Zydus bags tentative USFDA nod for Crohn's disease drug Budesonide delayed release

Gland Pharma profit rises 12 percent to Rs 184 crore in Q2

Bharat Biotech unveils Cell and Gene Therapy CRDMO - Nucelion

USFDA drug division chief George Tidmarsh resigns